Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mazyar Shadman

Showing results (21-30 of 224) with videos related to

Pageof 23
Sort By:
Current Oncology Reports|July 22, 2019
How to Choose the Best Treatment and Testing for Chronic Lymphocytic Leukemia in the Tsunami of New Treatment OptionsCecilia C S Yeung, Mazyar Shadman
The New England Journal of Medicine|May 3, 2023
Zanubrutinib in Chronic Lymphocytic Leukemia. ReplyJennifer R Brown, Aileen Cohen, Mazyar Shadman
BMC Public Health|May 4, 2006
Childhood trauma fatality and resource allocation in injury control programs in a developing countryBahman S Roudsari, Mazyar Shadman, Mohammad Ghodsi
Blood|June 20, 2018
Translating anti-CD19 CAR T-cell therapy into clinical practice for relapsed/refractory diffuse large B-cell lymphomaVictor A Chow, Mazyar Shadman, Ajay K Gopal
Blood Advances|May 20, 2026
"Immunologic Dream Team": BiTEs peri-allotransplant to redirect donor lymphocytes towards GVLLorenzo Iovino, Mazyar Shadman, Filippo Milano, et al.
Current Hematologic Malignancy Reports|December 3, 2025
The Evolving Therapeutic Landscape of Richter TransformationHenry Le, Grace Baek, Ivan Huang, et al.
Expert Opinion on Pharmacotherapy|August 30, 2024
Pharmacological management of chronic lymphocytic leukemia: current and emerging therapiesIvan J Huang, Grace T Baek, Chloe Siu, et al.
Oncology and Therapy|May 14, 2026
A Comprehensive Review of the Role of Zanubrutinib for Patients with Chronic Lymphocytic LeukemiaPaolo Ghia, Jennifer R Brown, Mazyar Shadman, et al.
Injury|October 29, 2003
Pediatric transport related injuries in Tehran: the necessity of implementation of injury prevention protocolsMoosa Zargar, Bahman Sayyar Roudsari, Mazyar Shadman, et al.
American Journal of Hematology|August 7, 2013
Associations between allergies and risk of hematologic malignancies: results from the VITamins and lifestyle cohort studyMazyar Shadman, Emily White, Anneclaire J De Roos, et al.
Pageof 23

Showing results (21-30 of 224) with videos related to

Sort By:
Pageof 23
Current Oncology Reports|July 22, 2019
How to Choose the Best Treatment and Testing for Chronic Lymphocytic Leukemia in the Tsunami of New Treatment OptionsCecilia C S Yeung, Mazyar Shadman
The New England Journal of Medicine|May 3, 2023
Zanubrutinib in Chronic Lymphocytic Leukemia. ReplyJennifer R Brown, Aileen Cohen, Mazyar Shadman
BMC Public Health|May 4, 2006
Childhood trauma fatality and resource allocation in injury control programs in a developing countryBahman S Roudsari, Mazyar Shadman, Mohammad Ghodsi
Blood|June 20, 2018
Translating anti-CD19 CAR T-cell therapy into clinical practice for relapsed/refractory diffuse large B-cell lymphomaVictor A Chow, Mazyar Shadman, Ajay K Gopal
Blood Advances|May 20, 2026
"Immunologic Dream Team": BiTEs peri-allotransplant to redirect donor lymphocytes towards GVLLorenzo Iovino, Mazyar Shadman, Filippo Milano, et al.
Current Hematologic Malignancy Reports|December 3, 2025
The Evolving Therapeutic Landscape of Richter TransformationHenry Le, Grace Baek, Ivan Huang, et al.
Expert Opinion on Pharmacotherapy|August 30, 2024
Pharmacological management of chronic lymphocytic leukemia: current and emerging therapiesIvan J Huang, Grace T Baek, Chloe Siu, et al.
Oncology and Therapy|May 14, 2026
A Comprehensive Review of the Role of Zanubrutinib for Patients with Chronic Lymphocytic LeukemiaPaolo Ghia, Jennifer R Brown, Mazyar Shadman, et al.
Injury|October 29, 2003
Pediatric transport related injuries in Tehran: the necessity of implementation of injury prevention protocolsMoosa Zargar, Bahman Sayyar Roudsari, Mazyar Shadman, et al.
American Journal of Hematology|August 7, 2013
Associations between allergies and risk of hematologic malignancies: results from the VITamins and lifestyle cohort studyMazyar Shadman, Emily White, Anneclaire J De Roos, et al.
Pageof 23